Kenneth Schuler is global Co-chair of Latham & Watkins' Intellectual Property Litigation Practice. Mr. Schuler joined Latham & Watkins in 1994 after serving as a judicial clerk to the Honorable James B. Loken, United States Court of Appeals for the Eighth Circuit. Since joining Latham, Mr. Schuler has acquired extensive litigation experience in federal and state courts, as well as in commercial arbitrations. He has extensive trial experience, having been admitted to the Trial Bar of the Northern District of Illinois in 2002.
Mr. Schuler’s practice primarily involves litigation concerning intellectual property rights, with a particular emphasis in pharmaceutical patent litigation involving claims arising under the Hatch-Waxman Act. Mr. Schuler has handled a number of such cases for clients such as Roxane Laboratories, Actavis, Orchid Chemicals & Pharmaceuticals, Boehringer-Ingelheim, Cadence Pharmaceuticals and Ben Venue Laboratories. He also has substantial experience litigating other intellectual property matters, including patent, trade secrets and trade dress suits, representing ADA Carbon Solutions, U.S. Bancorp, Owens-Brockway, Continental PET Technologies, Muth Mirror Systems and Libbey Glass, Inc., with respect to myriad technologies, including activated carbon, automotive signal mirrors, oxygen barrier plastic containers, ATM networks, mass spectrometers and diagnostics. In addition, Mr. Schuler has extensive experience involving securities, class action and complex commercial litigation, handling such matters for US Bancorp, Jefferies & Company, Nissan and National Presto Industries. Intellectual Asset Management magazine recently named Mr. Schuler to the 2014 IAM Patent 1000.